(image) Substance Abuse and Mental Health Services Administration Skip To Content
(image) Substance Abuse and Mental Health Services Administration (image) Substance Abuse and Mental Health Services Administration
(image) Substance Abuse and Mental Health Services Administration (image) Substance Abuse and Mental Health Services Administration (image) Substance Abuse and Mental Health Services Administration

Search SAMHSA Financing
Financing Main Menu
Topics
Post Type
Financing Center of Excellence

Retrospective assessment of Medicaid step-therapy prior authorization policy for atypical antipsychotic medications.

Posted on December 10, 2008 11:55

Topics: Expenditures | Medicaid | Mental Health | Outcomes | Prescription Drugs | Rates/Reimbursement/Cost

Post Type:

Using data from Georgia and Mississippi, this study assesses the effects of step-therapy prior authorization policy for atypical anti-psychotic medications on overall Medicaid expenditures as well as specific expenditures among schizophrenia patients.   

Farley, J. F., Cline, R. R., Schommer, J. C., Hadsall, R. S., & Nyman, J. A. (2008). Retrospective assessment of Medicaid step-therapy prior authorization policy for atypical antipsychotic medications. Clinical Therapeutics, 30(8), 1524-39; discussion 1506-7. DOI:10.1016/j.clinthera.2008.08.009    
Authors: Joel F. Farley, Richard R. Cline, Jon C. Schommer, Ronald S. Hadsall, John A. Nyman. 

E-mail to Friend | Print | Permalink | | Post RSSRSS comment feed

Subscribe
Recent Posts
Previous Posts
Centers and Offices